Search

New indications NexGard, NexGard SPECTRA and Broadline

New therapeutic indications for NexGard®, NexGard SPECTRA® and Broadline® approved by EMA

Boehringer Ingelheim and Mirati are teaming up in a clinical collaboration to evaluate the combination of the SOS1::pan-KRAS and the selective G12C inhibitor.

Boehringer Ingelheim acquires Global Stem cell Technology

Boehringer Ingelheim acquires Global Stem cell Technology, Belgian veterinary biotech company, to strengthen its stem cell capabilities in Animal Health

Veterinary oncology experts meet in Germany

Veterinary oncology experts meet prior to the European Society of Veterinary Oncology Congress in Hofheim, Germany

Arti-cell Forte stem cell-based veterinary product

Boehringer Ingelheim launches the first-ever registered stem cell-based veterinary medicine

FOYA_Shanghai

Boehringer Ingelheim’s commercial manufacturing facility in Shanghai has been awarded as “Facility of the Year”

Life stages of cats

Cats go through different stages of life. Knowing more about these stages can help you understand your cat’s medical needs better.

Risk of parasites in dogs

With our Parassess free online tool checker, you can assess the local parasite risks for your dog so you can protect them better.

Careers

Join a global team of more than 52,000 passionate and talented individuals dedicated to improving the health of humans and animals worldwide.

Pipeline Overview

Boehringer Ingelheim Human Pharma Clinical Pipeline

Work life wellness

We provide you with a range of benefits and services, including counselling, exercise classes, social events to help you stay mentally and physically fit.

Big Little Things in cancer: small things, big impacts

Little things can be a big deal when you are living with or treating cancer. Sometimes the small things are the most powerful.

Human Health Partnering

Animal Health Partnering

Building blocks of our future

Our global investment projects are the building blocks for improved healthcare and sustainability